0 6 min 3 weeks

The increasing prevalence of uterine cancer worldwide is driving the global “uterine cancer diagnostics testing market” says Fortune Business Insights in their new study. The study is titled,” Uterine Cancer Diagnostics Testing Market Size, Share and Global Trend by Type (Blood test, Endometrial biopsy, Imaging, Others), By End-user (Hospitals, Diagnostic centers, Cancer research centers, Others) and Geography Forecast till 2026”.

According to the report, the market is anticipated to be dominated by the endometrial biopsy segment on the basis of segmentation by type. This is because of the higher adoption of uterine testing diagnostics testing equipment and the cost associated with the process.

Request a Sample Copy of Research Report: 


Rising Prevalence of Uterine Cancer Driving Market

The global market for uterine cancer diagnostics testing is growing because of the rising incidence of cancer of the uterus worldwide. The National Cancer Institute of the U.S. states an estimate of 60,000 new cases of uterine cancer in 2019, which, in some cases, leads to gestational trophoblastic disease, where cells inside a woman’s uterus grows abnormally. The rising prevalence of uterine cancer is a major factor boosting the global market and anticipated to continue doing the same in the coming years as well.

The Canadian Cancer Society stated in 2017 the number of women diagnosed with uterine cancer in Canada alone was 7,300. The department of Health and Human Services estimates 11.0% of women between ages 15 to 40 years suffer from endometriosis every year in the U.S. the aforementioned factors are anticipated to drive the market remarkably in the coming years. This, coupled with, the rising prevalence of diabetes and people suffering from obesity per year in the U.S., are expected to boost the global market for uterine cancer diagnostics in the near future.

On the flipside, the market may face challenges in terms of high installation costs of uterine cancer diagnostic imaging systems, and the complications related to the patient’s maternity post biopsy procedure. Additionally, the lack of skilled doctors and shortage of healthcare resources such as radiologists in developing nations may also hamper the market in the coming years.

Nevertheless, government initiatives regarding theadopted to promote awareness about various cancer types and improvement in treatment facilities over the time is are anticipated to propel demand for uterine cancer therapeutics in the market. This, accompanied with the rising disposable income of the people is propelling people to opt for better treatment facilities.

Leading Players operating in the Uterine Cancer Diagnostics Testing Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

  • siemens healthcare private limited
  • bd
  • abbott
  • Hoffmann-la roche ltd.
  • biomérieux s. A.
  • Danaher

Asia Pacific to Witness Faster Growth on Account of Improving Healthcare Facilities in Emerging Economies

Fortune Business Insights foresees the global uterine cancer diagnostics testing market to be dominated by North America. This is because of the increasing prevalence of uterine cancer in the region. On the other hand, the market in Asia Pacific is anticipated to grow at faster rates because of the increasing healthcare facilities in the emerging economies of India, and China. This, accompanied with the rising awareness about various types of cancer, especially of the uterine is anticipated to bring lucrative opportunities for the market in Asia Pacific and help it emerge as the fastest growing region.

Companies operating in the global uterine cancer diagnostics testing market are Siemens Healthcare Private Limited, BD, Abbott, F. Hoffmann-La Roche Ltd., bioMérieux S. A., Danaher, and others.

Have Any Query? Ask Our Expert: 


Report Focus:

  • Extensive product offerings
  • Customer research services
  • Robust research methodology
  • Comprehensive reports
  • Latest technological developments
  • Value chain analysis
  • Potential Uterine Cancer Diagnostics Testing Market opportunities
  • Growth dynamics
  • Quality assurance
  • Post-sales support
  • Regular report updates

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.


US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:[email protected]

Linkedin | Twitter | BLogs


Related Reports :

Teledermatology Market

Teledermatology Market Size

Teledermatology Market Share

Teledermatology Market Trends

Teledermatology Market Growth

Teledermatology Market Analysis

Leave a Reply

Your email address will not be published. Required fields are marked *